Vycor Medical (VYCO) EBT (2010 - 2026)
Vycor Medical's (VYCO) quarterly EBT came in at $20095.0 in Q1 2026, up 152.18% year-on-year from $7968.6 in Q1 2025, and up 132.21% on a QoQ basis from -$62379.0 in Q4 2025.
Vycor Medical (VYCO) EBT (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of EBT data on file, last reported at $20095.0 in Q1 2026.
- On a quarterly basis, EBT rose 152.18% year-over-year to $20095.0 in Q1 2026; TTM through Mar 2026 was -$11581.0, a 87.11% increase from a year earlier, with the FY2025 full-year figure at -$70190.0, up 14.23% from the prior year.
- EBT for Q1 2026 stood at $20095.0, up from -$62379.0 in the prior quarter.
- Over the last five years, EBT for VYCO reached as high as $261471.0 in Q4 2022 and fell as low as -$112312.0 in Q3 2022.
- Historically, EBT has averaged -$12786.6 across 5 years, with a median of -$30507.0 in 2024.
- Across the five-year window, EBT plunged 10463.31% in 2022 and soared 357.41% in 2025, its largest moves.
- Year by year, EBT stood at $261471.0 in 2022, then tumbled by 134.41% to -$89961.0 in 2023, then surged by 120.49% to $18432.0 in 2024, then slumped by 438.43% to -$62379.0 in 2025, then jumped by 132.21% to $20095.0 in 2026.
- Per Business Quant data, the three most recent EBT figures were $20095.0 in Q1 2026, -$62379.0 in Q4 2025, and $4990.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 20,095.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,095.00 |
| Dec 31, 2025 | -62,379.00 |
| Sep 30, 2025 | 4,990.00 |
| Jun 30, 2025 | 25,713.00 |
| Mar 31, 2025 | -38,514.00 |
| Dec 31, 2024 | 18,432.00 |
| Sep 30, 2024 | -59,770.00 |
| Jun 30, 2024 | -9,989.00 |
| Mar 31, 2024 | -30,507.00 |
| Dec 31, 2023 | -89,961.00 |
| Sep 30, 2023 | -51,479.00 |
| Jun 30, 2023 | 70,791.00 |
| Mar 31, 2023 | 7,569.00 |
| Dec 31, 2022 | 261,471.00 |
| Sep 30, 2022 | -112,312.00 |
| Jun 30, 2022 | -97,726.00 |
| Mar 31, 2022 | -73,797.00 |
| Dec 31, 2021 | 185,019.00 |
| Sep 30, 2021 | 7,659.00 |
| Jun 30, 2021 | 943.00 |